Shanghai Medicilon Inc. (SHA:688202)
China · Delayed Price · Currency is CNY 77.90
-3.89 (-4.76%)
Oct 22, 2026, 4:00 PM EDT
Shanghai Medicilon Market Cap
Shanghai Medicilon has a market cap or net worth of 10.25 billion as of October 22, 2026. It is the 7,768th most valuable company in the world and the 1,502nd biggest in China. Its market cap has increased by 22.48% in one year.
Market Cap
10.25B
Enterprise Value
9.92B
Revenue
1.38B
Global Rank
Country Rank
#1,502 China
PE Ratio
n/a
ChartMarket Cap Chart
Since November 5, 2019, Shanghai Medicilon's market cap has increased from 4.40B to 10.25B, an increase of 132.79%. That is a compound annual growth rate of 12.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 10.25B | 38.12% |
| Dec 31, 2025 | 7.42B | 83.97% |
| Dec 31, 2024 | 4.03B | -56.21% |
| Dec 29, 2023 | 9.21B | -50.52% |
| Dec 30, 2022 | 18.61B | -38.26% |
| Dec 31, 2021 | 30.15B | 209.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Nov 5, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| GemPharmatech | 12.38B |
| Nanjing Vazyme Biotech | 11.53B |
| Hualan Biological Vaccine | 11.43B |
| Tibet Cheezheng Tibetan Medicine | 10.90B |
| Chengdu Olymvax Biopharmaceuticals | 10.82B |
| Inner Mongolia Furui Medical Science | 10.58B |
| Chengzhi | 9.87B |
| Staidson (Beijing) BioPharmaceuticals | 9.86B |